Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus-based immunosuppression without calcineurin inhibitors in HCV-infected liver transplant patients
2007-006221-27Phase 3Active
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of everolimus in hepatitis C virus infection and Hepatitis C-related cirrhosis (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoints: Incidence and severity of histologically-proven rejection episodes, Patient survival and 1 more. Started Jun 2008; status: active.
02
Drugs
everolimus
03
Conditions
hepatitis C virus infectionHepatitis C-related cirrhosis
Beyond the preview
Go deeper on 2007-006221-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006221-27.